Blake R. Peterson, Ph.D.
Chair of Scientific Advisory Board
Currently holds the position of Regents Distinguished Professor of Medicinal Chemistry at the University of Kansas. Formerly an Associate Professor of Chemistry at Penn State University, his educational background includes a Ph.D. in Chemistry from UCLA and research experience as a Damon Runyon-Walter Winchell Cancer Research Postdoctoral Fellow at Harvard University. In his academic research at the interface between chemistry and biology, he has published over 65 peer-reviewed manuscripts and been involved in over $40,000,000 in externally funded research projects.
Dr. John (Jack) Vanden Heuvel
One of the Company’s original founders, and currently serves as Chief Scientific Officer. Dr. Vanden Heuvel is a recognized expert in the field of nuclear receptor biology and toxicology with over 100 peer-reviewed publications. In addition to his role as CSO at INDIGO, Dr. Vanden Heuvel is a Professor at Penn State University where he is Program Coordinator of the undergraduate Toxicology Program, Co-Director of the Center of Excellence in Nutrigenomics and leads an extramurally funded research program. Dr. Vanden Heuvel may be contacted via e-mail at firstname.lastname@example.org
Dr. Bruce A. Sherf
Dr. Sherf joined the Company in 2008 as the Chief Technology Officer. He has worked in the biotechnology industry since 1994, has particular expertise in cell-based reporter assay design and optimization, product development, and high-throughput screening applications for drug discovery. As CTO, he oversees INDIGO Biosciences’ product development, manufacturing, and technology transfer initiatives, as well as directing all Contract Services related activities. Dr. Sherf may be contacted via e-mail at email@example.com